These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 9423936

  • 1. 5-HT2A/2C receptor agonists potentiate the discriminative cue of (+)-amphetamine in the rat.
    Marona-Lewicka D, Nichols DE.
    Neuropharmacology; 1997 Oct; 36(10):1471-5. PubMed ID: 9423936
    [Abstract] [Full Text] [Related]

  • 2. LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex.
    Marek GJ, Aghajanian GK.
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1373-82. PubMed ID: 8819525
    [Abstract] [Full Text] [Related]

  • 3. Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis.
    Marona-Lewicka D, Thisted RA, Nichols DE.
    Psychopharmacology (Berl); 2005 Jul; 180(3):427-35. PubMed ID: 15723230
    [Abstract] [Full Text] [Related]

  • 4. Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex.
    Gresch PJ, Smith RL, Barrett RJ, Sanders-Bush E.
    Neuropsychopharmacology; 2005 Sep; 30(9):1693-702. PubMed ID: 15756304
    [Abstract] [Full Text] [Related]

  • 5. Hallucinogenic 5-HT2AR agonists LSD and DOI enhance dopamine D2R protomer recognition and signaling of D2-5-HT2A heteroreceptor complexes.
    Borroto-Escuela DO, Romero-Fernandez W, Narvaez M, Oflijan J, Agnati LF, Fuxe K.
    Biochem Biophys Res Commun; 2014 Jan 03; 443(1):278-84. PubMed ID: 24309097
    [Abstract] [Full Text] [Related]

  • 6. LSD and DOB: interaction with 5-HT2A receptors to inhibit NMDA receptor-mediated transmission in the rat prefrontal cortex.
    Arvanov VL, Liang X, Russo A, Wang RY.
    Eur J Neurosci; 1999 Sep 03; 11(9):3064-72. PubMed ID: 10510170
    [Abstract] [Full Text] [Related]

  • 7. Serotonergic and dopaminergic distinctions in the behavioral pharmacology of (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD).
    Schindler EA, Dave KD, Smolock EM, Aloyo VJ, Harvey JA.
    Pharmacol Biochem Behav; 2012 Mar 03; 101(1):69-76. PubMed ID: 22197710
    [Abstract] [Full Text] [Related]

  • 8. Substituted hexahydrobenzodipyrans as 5-HT2A/2C receptor probes.
    Whiteside MS, Kurrasch-Orbaugh D, Marona-Lewicka D, Nichols DE, Monte A.
    Bioorg Med Chem; 2002 Oct 03; 10(10):3301-6. PubMed ID: 12150876
    [Abstract] [Full Text] [Related]

  • 9. Involvement of 5-hydroxytryptamine 2A (5-HT2A) receptors in the mediation of the discriminative stimulus properties of (+/-)DOI in rats.
    Chojnacka-Wójcik E, Kłodzińska A.
    Pol J Pharmacol; 1997 Oct 03; 49(5):299-304. PubMed ID: 9566028
    [Abstract] [Full Text] [Related]

  • 10. Phospholipase C mediates (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-, but not lysergic acid diethylamide (LSD)-elicited head bobs in rabbit medial prefrontal cortex.
    Schindler EA, Harvey JA, Aloyo VJ.
    Brain Res; 2013 Jan 23; 1491():98-108. PubMed ID: 23123701
    [Abstract] [Full Text] [Related]

  • 11. Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in mice and rats.
    Fantegrossi WE, Harrington AW, Eckler JR, Arshad S, Rabin RA, Winter JC, Coop A, Rice KC, Woods JH.
    Psychopharmacology (Berl); 2005 Sep 23; 181(3):496-503. PubMed ID: 15983786
    [Abstract] [Full Text] [Related]

  • 12. Dopamine D4 receptor involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen DOI.
    Marona-Lewicka D, Chemel BR, Nichols DE.
    Psychopharmacology (Berl); 2009 Apr 23; 203(2):265-77. PubMed ID: 18604600
    [Abstract] [Full Text] [Related]

  • 13. Effects of hallucinogens on locomotor and investigatory activity and patterns: influence of 5-HT2A and 5-HT2C receptors.
    Krebs-Thomson K, Paulus MP, Geyer MA.
    Neuropsychopharmacology; 1998 May 23; 18(5):339-51. PubMed ID: 9536447
    [Abstract] [Full Text] [Related]

  • 14. Mechanism of tolerance development to 2,5-dimethoxy-4-iodoamphetamine in rats: down-regulation of the 5-HT2A, but not 5-HT2C, receptor.
    Smith RL, Barrett RJ, Sanders-Bush E.
    Psychopharmacology (Berl); 1999 Jun 23; 144(3):248-54. PubMed ID: 10435391
    [Abstract] [Full Text] [Related]

  • 15. Serotonin type 5A receptor antagonists inhibit D-lysergic acid diethylamide discriminatory cue in rats.
    Popik P, Krawczyk M, Kuziak A, Bugno R, Hogendorf A, Staroń J, Nikiforuk A.
    J Psychopharmacol; 2019 Nov 23; 33(11):1447-1455. PubMed ID: 31452444
    [Abstract] [Full Text] [Related]

  • 16. Effects of the serotonin 5-HT2A and 5-HT2C receptor ligands on the discriminative stimulus effects of nicotine in rats.
    Zaniewska M, McCreary AC, Przegaliński E, Filip M.
    Eur J Pharmacol; 2007 Oct 01; 571(2-3):156-65. PubMed ID: 17617403
    [Abstract] [Full Text] [Related]

  • 17. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS, Assié MB, Koek W.
    J Pharmacol Exp Ther; 1997 Aug 01; 282(2):747-59. PubMed ID: 9262338
    [Abstract] [Full Text] [Related]

  • 18. Involvement of 5-HT2C receptors in mediating the discriminative stimulus properties of m-chlorophenylpiperazine (mCPP).
    Callahan PM, Cunningham KA.
    Eur J Pharmacol; 1994 May 12; 257(1-2):27-38. PubMed ID: 8082704
    [Abstract] [Full Text] [Related]

  • 19. Dihydrobenzofuran analogues of hallucinogens. 4. Mescaline derivatives.
    Monte AP, Waldman SR, Marona-Lewicka D, Wainscott DB, Nelson DL, Sanders-Bush E, Nichols DE.
    J Med Chem; 1997 Sep 12; 40(19):2997-3008. PubMed ID: 9301661
    [Abstract] [Full Text] [Related]

  • 20. The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. III: The mechanistic basis for supersensitivity to the LSD stimulus following serotonin depletion.
    Fiorella D, Helsley S, Lorrain DS, Rabin RA, Winter JC.
    Psychopharmacology (Berl); 1995 Oct 12; 121(3):364-72. PubMed ID: 8584619
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.